SUMMARY Recurrent venous thrombosis presents a diagnostic challenge. Venography, impedance plethysmography and fibrinogen leg scanning all have potential limitations, and their role in this context has not been evaluated. We performed a prospective cohort study evaluating impedance plethysmography and leg scanning, plus venography, using outcome on long-term follow-up as the end point in 270 patients with clinically suspected recurrent deep-vein thrombosis. Anticoagulant treatment was withheld in the 181 patients negative by noninvasive testing and was given in patients positive by impedance plethysmography if leg scanning was positive or if intraluminal filling defects were detected by venography. The validity of this approach was tested by long-term follow-up. Three of 181 patients (1.7%) negative by noninvasive testing had a recurrence, compared with 18 of 89 (20%) with positive findings (p < 0.001). (abnormal findings by venography characterized by recanalization, obliteration, loss of filling of segments) and a negative leg scan result presented a dilemma; in these patients, anticoagulant therapy was withheld. Anticoagulant therapy was given according to the following regimen: Full-dose i.v. heparin therapy was given for 7-10 days to maintain the partial thromboplastin time at 1.5-2 times control value. Warfarin sodium therapy was commenced at a dose of 10 mg/ day for the first 2 days and then adjusted according to the prothrombin time (Simplastin; General Diagnostics), which was maintained at 1.5-2 times control value; warfarin sodium therapy and i.v. heparin therapy were overlapped for 4 days and warfarin sodium therapy was continued for 3 months.
The methods for performing and interpreting occlusive cuff impedance plethysmography (using optimal venous filling) have been described7' 8 and are summarized in the Appendix. The methods for performing and interpreting '251-fibrinogen leg scanning and venography have also been described.37 8
Two experienced observers independently interpreted the findings by impedance plethysmography, 1251_ fibrinogen leg scanning and venography; disputes were resolved through adjudication by a third. The results of leg scanning, impedance plethysmography and venography were interpreted independently of each other and without knowledge of the patient' s condition. The radiographic criterion used for acute venous thrombosis was the presence of an intraluminal filling defect that was constant in two or more films. If the deep venous system was poorly visualized with either recanalization or nonfilling (with or without collaterals) despite repeated examination, the venogram was coded as "indeterminate." All patients were then followed long term. Each In patients with clinically suspected recurrent deepvein thrombosis, the diagnosis was confirmed by objective testing with impedance plethysmography, leg scanning and venography using the diagnostic criteria applied on entry. In patients with clinically suspected, nonfatal pulmonary embolism, the diagnosis was confirmed by pulmonary angiography. The diagnostic end point for pulmonary embolism was the presence of constant intraluminal filling defects by pulmonary angiography or pulmonary embolism found at autopsy.
Confidence limits for the complication rates during long-term follow-up were calculated from the binomial distribution. The difference in the outcome during long-term follow-up between patients negative by impedance plethysmography and leg scanning and positive by impedance plethysmography or leg scan was analyzed by Fisher's exact test (for death due to pulmonary embolism) and by the chi-square method (for all venous thromboembolic events). Fourteen patients returned during long-term followup with nonfatal recurrent venous thromboembolism; 13 patients had recurrent venous thrombosis and one patient had pulmonary embolism. Two of the 14 patients returned 2 weeks after entry, 10 between the 3 and 12 months and two after 12 months. Eight months after entry, one patient developed pleuritic chest pain after major knee surgery, and pulmonary angiography confirmed the presence of pulmonary embolism. Two patients returned 2 weeks after entry with objectively documented, acute, recurrent, deep-vein thrombosis confirmed by both noninvasive testing and venography; neither patient was receiving warfarin at the time of recurrence. Both patients had new intraluminal filling defects in the proximal venous system that were not present in the initial venograms. Nine patients returned between 3 and 12 months after entry with objectively documented, acute, recurrent, deep-vein thrombosis by both noninvasive testing and venography; in seven, venography demonstrated constant intraluminal filling defects in the proximal venous system that were not present in the initial venogram and, in two, new constant intraluminal filling defects were detected in the calf. Two patients returned after the 12-month follow-up with objectively documented, recurrent, deep-vein thrombosis by noninvasive testing and venography; venography demonstrated new constant intraluminal filling defects in the proximal venous system. Interestingly, the impedance plethysmography result was normal before the acute episode of recurrent venous thrombosis during long-term follow-up in 12 of the 13 patients with recurrent venous thrombosis; at the time of the subsequent acute recurrent event, the impedance plethysmography result had changed from normal to abnormal in all 12 patients.
Results
An additional six patients in this group died during follow-up, five from disseminated carcinoma and one from a cerebrovascular accident.
Comparison of Long-Term Outcome in Positive and Negative Cohorts
Four of 89 patients (4.5%) in whom the results of impedance plethysmography and leg scanning were positive died from massive pulmonary embolism, compared with none of 181 patients in whom impedance plethysmography and leg scans were negative (p = 0.01). Three of 181 patients with objectively documented recurrent venous thromboembolism died, a frequency of 1.7% (95% confidence interval 0.4-4.8%). In contrast, 18 of 89 patients positive by impedance plethysmography or leg scanning died, a frequency of 20.2% (95% confidence interval 12.5-30.1 %). The difference between these two groups was statistically significant (p < 0.001).
Discussion
The results of this prospective clinical trial indicate that the objective diagnostic process evaluated here can be used to separate patients with clinically suspected recurrence into two groups: a negative cohort in whom it is safe to withhold anticoagulant therapy and a positive cohort that requires anticoagulant therapy. The observations made by prospective comparative study with long-term follow-up have important clinical implications. One hundred eighty-one of 270 patients (67%) had negative impedance plethysmography and leg scan results; only three of these 181 patients (1.7%) returned with recurrent venous thromboembolism during long-term follow-up, and no patient died from pulmonary embolism. In contrast, patients with positive impedance plethysmography or leg scan results had a high frequency of acute, recurrent, deep-vein thrombosis during long-term follow up; 18 of 89 (20.2%) had new episodes of objectively documented venous thromboembolism, including four deaths from pulmonary embolism (p < 0.001). In the majority of positive patients, recurrent venous thromboembolism occurred after anticoagulant therapy had been terminated either inadvertently or after 3 months.
The diagnostic approach we used has a high clinical value. We established definitive management in 257 of 270 patients (95%). In the remaining 13 patients (5%) who had a positive impedance plethysmography result, an indeterminate venogram result and a negative leg scan result, acute, recurrent venous thromboembolism could not be confidently ruled out. These patients were not treated, but it can be argued that they should have been because the leg scan may have failed to detect proximal vein thrombosis in the upper thigh or in the axial veins of the pelvis. Given the infrequency of this combination of test results, it would be prudent to err on the side of treating these patients rather than to risk death from massive embolism.
Our findings indicate that patients in the positive cohort had a surprisingly poor prognosis; 18 of these 89 patients (20%) had a recurrence of thromboembolism. This high frequency suggests that patients positive by impedance plethysmography or leg scanning may not have been treated long enough. We are performing a randomized trial to determine whether a longer course of oral anticoagulant therapy is preferable to 3 months of therapy.
Our findings suggest that a baseline impedance plethysmography evaluation performed as a part of routine follow-up has clinical value. The majority of patients returning on long-term follow-up with a further episode of recurrent deep-vein thrombosis had impedance plethysmography results that had become normal but reverted to abnormal at the time of the recurrence.
Our results are of considerable clinical relevance because, for the first time, the clinician is provided with a practical approach to the patient with clinically suspected, recurrent, deep-vein thrombosis. The use of noninvasive tests and venography in such patients is highly cost effective, for 181 of 270 patients (67%) were spared the need for in-hospital care and long-term anticoagulant therapy.
itive testing and prolonged cuff occlusion. Five tests were performed at each examination. The duration of occlusion during these tests was 45, 45, 120, 45 and 120 seconds, and the time interval between them was 20-30 seconds.8 We used this protocol because optimal venous filling rarely occurred until the leg was subjected to three to five cycles of inflation and deflation as well as prolonged venous occlusion. 7 Scoring and Interpretation of the Impedance
Plethysmograph Results
The rise and fall of each test were both plotted on the two-way graph containing the discriminant line (fig. 3) ; the point used as the patient's plethysmograph result was that which showed the highest rise and VENOUS CAPACITANCE RISE) FIGURE 3. To score the impedance plethysmography result, the rise (venous capacitance) andfall (venous outflow in three seconds) of each test were plotted on the two-way graph containing the discriminant line. The point used as the patient's plethysmography result was that which showed the highest rise and greatestfall. This result was coded as "normal" if itfell above the discriminant line, and "abnormal" ifit landed on or below the discriminant line. 
